Neurogene Inc. (NGNE) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
NGNE Revenue Growth
Revenue Breakdown (FY 2024)
NGNE's revenue distribution by segment and geography for fiscal year 2024
By Product/Segment
NGNE Revenue Analysis (2014–2025)
As of May 8, 2026, Neurogene Inc. (NGNE) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q4 2025) recorded $0 in revenue.
Looking at the longer-term picture, NGNE's historical revenue data shows various trends over time. The company achieved its highest annual revenue of $25.0 million in 2018.
Revenue diversification analysis shows NGNE's business is primarily driven by Reportable Segment (100%). With over half of revenue concentrated in Reportable Segment, the company maintains significant focus in this area while developing other growth vectors.
When compared to Healthcare sector peers including KRYS (+25.1% YoY), ARQT (+95.3% YoY), and RARE (+13.3% YoY). Compare NGNE vs KRYS →
NGNE Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| NGNECurrent | $0 | - | - | - | |
 KRYS | $389M | +25.1% | - | 41.5% | |
 ARQT | $376M | +95.3% | - | -3.3% | |
 RARE | $673M | +13.3% | +19.9% | -79.5% |
NGNE Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | -100.0% | $-3,192,000 | - | $-103,208,000 | - |
| 2024 | $925K | - | $-2,322,000 | -251.0% | $-82,605,000 | -8930.3% |
| 2023 | $0 | - | $-3,262,000 | - | $-55,583,000 | - |
| 2022 | $0 | - | $-3,196,000 | - | $-56,517,000 | - |
| 2021 | $0 | - | $-42,264,000 | - | $-50,534,000 | - |
| 2020 | $0 | - | $-1,821,000 | - | $-41,554,000 | - |
| 2019 | $0 | -100.0% | $-340,000 | - | $-24,443,000 | - |
| 2018 | $25.0M | - | $25.0M | 100.0% | $-23,524,000 | -94.1% |
| 2017 | $0 | - | $0 | - | $-51,119,000 | - |
| 2016 | $0 | - | $0 | - | $-37,645,000 | - |
See NGNE's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs NGNE Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare NGNE vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonNGNE — Frequently Asked Questions
Quick answers to the most common questions about buying NGNE stock.
Is NGNE's revenue growth accelerating or slowing?
NGNE TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is NGNE's long-term revenue growth rate?
Neurogene Inc.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is NGNE's revenue distributed by segment?
NGNE reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.